Evidence map›Paper›PMID 34415473›Full record

Observational studyInternational urology and nephrology2022

Immunological parameters associated with the severity of COVID-19 pneumonia in kidney transplant recipients.

Abdullah Ozkok, Nadir Alpay, Servet Alan, Nur Dilek Bakan, Fusun Soysal, Halil Yazici, Emel Ekşioğlu-Demiralp, Alaattin Yildiz

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in International urology and nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Abdullah OzkokDepartment of Nephrology and Kidney Transplantation, Memorial Şişli Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5622-6792
Nadir AlpayDepartment of Nephrology and Kidney Transplantation, Memorial Hizmet Hospital, Istanbul, Turkey.
Servet AlanDepartment of Infectious Diseases and Clinical Microbiology, Memorial Şişli Hospital, Istanbul, Turkey.
Nur Dilek BakanDepartment of Chest Diseases, Memorial Şişli Hospital, Istanbul, Turkey.
Fusun SoysalDepartment of Chest Diseases, Memorial Şişli Hospital, Istanbul, Turkey.
Halil YaziciDepartment of Nephrology and Kidney Transplantation, Memorial Şişli Hospital, Istanbul, Turkey.
Emel Ekşioğlu-DemiralpDepartment of Immunology, Memorial Şişli Hospital, Istanbul, Turkey.
Alaattin YildizDepartment of Nephrology and Kidney Transplantation, Memorial Şişli Hospital, Istanbul, Turkey. alaattin.yildiz@yahoo.com.
Memorial Sisli Hospital · TRIstanbul Memorial Hospital · TRÜsküdar University · TRYıldız Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAn outbreak of a novel respiratory disease due to coronavirus species was emerged in 2019 and named as Coronavirus Disease-2019 (COVID-19). Clinical and immunological factors affecting the course of COVID-19 in kidney transplant recipients (KTR) are not well-known.

methodsIn this prospective observational study, we presented 20 KTR with COVID-19 pnemonia and examined the factors predicting the severity of COVID-19. A total of 10 KTR without COVID-19 was used as control group. Lymphocyte subsets were determined by flow cytometry. In 13/20 patients, immunophenotyping was repeated 1 week later.

resultsMean age of the patients was 50 ± 9 years. Patients were classified as mild-moderate (oxygen saturation: SO

conclusionIn this pilot study, increased NK cells, activated CD8 + cells and decreased CD3 + and CD4 + cells were associated with severity of COVID-19 in KTR. Peripheral immunophenotyping of lymphocyte subtypes may provide prognostic information about the clinical course of COVID-19 in KTR.

Indexed as

COVID-19Kidney TransplantationAdultHumansLymphocyte CountLymphocyte SubsetsMiddle AgedPilot ProjectsTransplant RecipientsCOVID-19Flow cytometryKidney transplantationLymphocytesNatural killer cellsT cells

Identifiers

PMID34415473
PMCPMC8377705
OpenAlexW3193865349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.